Globeflex Capital L P lowered its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 22.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 82,686 shares of the business services provider's stock after selling 24,447 shares during the period. Globeflex Capital L P owned 0.25% of Cross Country Healthcare worth $1,502,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of the stock. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Cross Country Healthcare in the 4th quarter valued at $1,084,000. Inspire Advisors LLC boosted its holdings in Cross Country Healthcare by 53.8% in the fourth quarter. Inspire Advisors LLC now owns 34,752 shares of the business services provider's stock valued at $631,000 after acquiring an additional 12,159 shares during the last quarter. Alpine Associates Management Inc. acquired a new stake in Cross Country Healthcare in the fourth quarter worth about $10,552,000. Amundi raised its holdings in Cross Country Healthcare by 385.4% during the 4th quarter. Amundi now owns 26,494 shares of the business services provider's stock worth $483,000 after purchasing an additional 21,036 shares during the last quarter. Finally, Dana Investment Advisors Inc. lifted its position in Cross Country Healthcare by 36.6% during the 4th quarter. Dana Investment Advisors Inc. now owns 552,875 shares of the business services provider's stock valued at $10,040,000 after purchasing an additional 148,160 shares during the period. Institutional investors own 96.03% of the company's stock.
Wall Street Analysts Forecast Growth
CCRN has been the subject of a number of recent research reports. StockNews.com assumed coverage on shares of Cross Country Healthcare in a research note on Wednesday, March 12th. They set a "hold" rating for the company. Truist Financial increased their price target on Cross Country Healthcare from $15.00 to $18.61 and gave the company a "hold" rating in a research note on Thursday, December 5th. JMP Securities reaffirmed a "market perform" rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. William Blair downgraded Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. Finally, Barrington Research restated a "market perform" rating and set a $18.61 target price on shares of Cross Country Healthcare in a report on Friday, March 14th. Six equities research analysts have rated the stock with a hold rating, According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $18.41.
Check Out Our Latest Report on CCRN
Cross Country Healthcare Trading Up 0.3 %
Shares of CCRN stock traded up $0.05 on Wednesday, hitting $14.94. The stock had a trading volume of 381,259 shares, compared to its average volume of 582,514. Cross Country Healthcare, Inc. has a twelve month low of $9.58 and a twelve month high of $19.25. The company has a fifty day moving average price of $17.56 and a two-hundred day moving average price of $15.18. The firm has a market cap of $490.23 million, a P/E ratio of -298.74, a PEG ratio of 3.32 and a beta of 0.44.
Cross Country Healthcare Profile
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.